Onex Canada Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.03M Buy
12,268
+197
+2% +$107K 1% 30
2025
Q4
$6.99M Sell
12,071
-476
-4% -$269K 0.97% 32
2025
Q3
$6.09M Buy
12,547
+97
+0.8% +$45.1K 0.77% 40
2025
Q2
$5.05M Buy
12,450
+294
+2% +$123K 0.62% 46
2025
Q1
$6.05M Sell
12,156
-35
-0.3% -$19K 0.78% 43
2024
Q4
$6.34M Buy
12,191
+437
+4% +$240K 0.76% 38
2024
Q3
$7.27M Hold
11,754
0.85% 33
2024
Q2
$6.5M Buy
11,754
+80
+0.7% +$45.8K 0.74% 40
2024
Q1
$6.79M Sell
11,674
-984
-8% -$552K 0.68% 50
2023
Q4
$6.72M Sell
12,658
-3,854
-23% -$1.87M 0.66% 53
2023
Q3
$8.36M Sell
16,512
-1,345
-8% -$717K 0.64% 52
2023
Q2
$9.32M Sell
17,857
-2,695
-13% -$1.45M 0.56% 58
2023
Q1
$11.8M Sell
20,552
-2,391
-10% -$1.35M 0.65% 50
2022
Q4
$12.6M Buy
22,943
+3,986
+21% +$2.11M 0.71% 48
2022
Q3
$9.62M Buy
18,957
+905
+5% +$506K 0.57% 54
2022
Q2
$9.81M Sell
18,052
-190
-1% -$105K 0.54% 57
2022
Q1
$10.8M Sell
18,242
-29
-0.2% -$16.7K 0.47% 66
2021
Q4
$12.2M Buy
18,271
+175
+1% +$109K 0.5% 61
2021
Q3
$10.3M Buy
18,096
+26
+0.1% +$14.3K 0.43% 68
2021
Q2
$9.12M Buy
18,070
+62
+0.3% +$29.3K 0.42% 71
2021
Q1
$8.22M Sell
18,008
-55
-0.3% -$26.3K 0.37% 80
2020
Q4
$8.41M Sell
18,063
-221
-1% -$104K 0.58% 62
2020
Q3
$8.07M Sell
18,284
-332
-2% -$137K 0.53% 63
2020
Q2
$6.75M Sell
18,616
-2,671
-13% -$895K 0.45% 69
2020
Q1
$6.04M Buy
21,287
+272
+1% +$85.8K 0.4% 78
2019
Q4
$6.69M Sell
21,015
-140
-0.7% -$42.5K 0.38% 73
2019
Q3
$6.16M Buy
+21,155
New +$6.06M 0.39% 67
2015
Q1
Sell
-425,099
Closed -$53.3M 84
2014
Q4
$53.3M Buy
425,099
+182,739
+75% +$22.2M 3.12% 11
2014
Q3
$29.5M Buy
242,360
+1,680
+0.7% +$204K 2.21% 20
2014
Q2
$28.4M Buy
240,680
+17,090
+8% +$2.01M 1.92% 21
2014
Q1
$26.9M Buy
+223,590
New +$26.6M 1.72% 25

Other funds holding TMO

Onex Canada Asset Management's TMO Position: Q1 2026 in Review

Onex Canada Asset Management increased its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, buying an estimated $107K and bringing the position to 12,268 shares worth $6.03M. The position accounts for 1% of the portfolio, ranked #30.

Onex Canada Asset Management first reported a position in TMO in Q1 2014 and has held it in 31 quarters since. The position peaked at $53.3M in Q4 2014. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Onex Canada Asset Management held 12,268 shares of Thermo Fisher Scientific worth $6.03M as of Q1 2026.
  • Onex Canada Asset Management bought 197 Thermo Fisher Scientific shares in Q1 2026, an estimated $107K.
  • Thermo Fisher Scientific made up 1% of Onex Canada Asset Management's portfolio in Q1 2026, its #30 holding.
  • Onex Canada Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 31 quarters since.
  • Onex Canada Asset Management's Thermo Fisher Scientific position peaked at $53.3M in Q4 2014.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Onex Canada Asset Management's 13F filing for Q1 2026, filed 15 May 2026.